Suvretta Capital Management 13F holdings, Q2 2023
Holdings as of June 30, 2023 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 100 US equity positions worth $1.9bn in its Q2 2023 13F filing. The largest position was RPRX at 5.0% of the reported book, followed by BHVN and ARCELLX INC. Against the Q1 2023 filing, it opened 13 new positions, added to 18 and reduced 13 among the top 50 holdings.
What did Suvretta Capital Management own in Q2 2023? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2023 |
|---|---|---|---|---|---|---|---|
| 1 | RPRX ROYALTY PHARMA PLC | Healthcare | 5.0% | $93.7m | 3,047,049 | 0% | held |
| 2 | BHVN BIOHAVEN LTD | Healthcare | 4.9% | $92.5m | 3,867,558 | 0% | held |
| 3 | ARCELLX INC | 4.8% | $90.1m | 2,848,167 | 19% | added | |
| 4 | HORIZON THERAPEUTICS PUB L | 4.4% | $81.6m | 793,355 | -19% | reduced | |
| 5 | INTRA-CELLULAR THERAPIES INC | 4.1% | $75.9m | 1,198,971 | 0% | held | |
| 6 | KURA KURA ONCOLOGY INC | Healthcare | 4.0% | $74.4m | 7,028,442 | 7% | added |
| 7 | META META PLATFORMS INC | Communication Services | 3.9% | $72.1m | 251,230 | -29% | reduced |
| 8 | 290A CHINOOK THERAPEUTICS INC | 3.6% | $67.2m | 1,748,141 | 11% | added | |
| 9 | INSM INSMED INC | Healthcare | 3.5% | $65.6m | 3,109,334 | 6% | added |
| 10 | 430 TERNS PHARMACEUTICALS INC | 2.6% | $48.7m | 5,561,835 | 61% | added | |
| 11 | 89BIO INC | 2.4% | $45.4m | 2,393,236 | 8% | added | |
| 12 | MARINUS PHARMACEUTICALS INC | 2.4% | $44.1m | 4,057,611 | -16% | reduced | |
| 13 | AMZN AMAZON COM INC | Consumer Cyclical | 2.3% | $42.7m | 327,913 | -41% | reduced |
| 14 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.3% | $42.2m | 370,607 | -41% | reduced |
| 15 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 2.1% | $39.7m | 685,233 | – | new |
| 16 | ORCL ORACLE CORP | Technology | 2.0% | $37.9m | 318,425 | -13% | reduced |
| 17 | PROK PROKIDNEY CORP | 1.9% | $35.7m | 3,193,175 | 0% | held | |
| 18 | NVDA NVIDIA CORPORATION | Technology | 1.8% | $32.8m | 77,492 | – | new |
| 19 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 1.7% | $31.5m | 298,658 | -54% | reduced |
| 20 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.6% | $29.8m | 3,423,897 | 1% | added |
| 21 | XYZ BLOCK INC | Technology | 1.5% | $28.8m | 432,296 | 18% | added |
| 22 | GPN GLOBAL PMTS INC | Industrials | 1.5% | $27.7m | 281,188 | – | new |
| 23 | RH RH | Consumer Cyclical | 1.5% | $27.4m | 83,189 | – | new |
| 24 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.5% | $27.4m | 5,883,693 | 3% | added |
| 25 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.4% | $26.3m | 2,219,693 | 22% | added |
| 26 | INFLARX NV | 1.4% | $25.6m | 5,733,910 | 167% | added | |
| 27 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.3% | $25.0m | 541,480 | -12% | reduced |
| 28 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 1.3% | $23.9m | 237,031 | – | new |
| 29 | ZURA ZURA BIO LTD | Healthcare | 1.2% | $23.4m | 2,850,000 | – | new |
| 30 | COF CAPITAL ONE FINL CORP | Financial Services | 1.2% | $21.7m | 198,570 | -4% | reduced |
| 31 | ACCENTURE PLC IRELAND | 1.2% | $21.6m | 70,103 | – | new | |
| 32 | GE GENERAL ELECTRIC CO | Industrials | 1.1% | $21.2m | 192,734 | – | new |
| 33 | CP CANADIAN PACIFIC KANSAS CITY | Industrials | 1.1% | $20.9m | 259,073 | – | new |
| 34 | GS GOLDMAN SACHS GROUP INC | Financial Services | 1.1% | $20.3m | 63,091 | 9% | added |
| 35 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.0% | $18.9m | 5,718,881 | 10% | added |
| 36 | DISCOVER FINL SVCS | 1.0% | $18.8m | 161,056 | – | new | |
| 37 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.0% | $18.3m | 2,034,506 | 3% | added | |
| 38 | WFC WELLS FARGO CO NEW | Financial Services | 1.0% | $18.1m | 423,506 | 26% | added |
| 39 | PINS PINTEREST INC | Communication Services | 1.0% | $18.0m | 658,390 | -27% | reduced |
| 40 | KEZAR LIFE SCIENCES INC | 0.9% | $17.6m | 7,167,591 | 4% | added | |
| 41 | ACTIVISION BLIZZARD INC | 0.9% | $17.5m | 207,188 | – | new | |
| 42 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 0.9% | $16.7m | 114,862 | -73% | reduced |
| 43 | WORLD WRESTLING ENTMT INC | 0.9% | $16.3m | 150,008 | – | new | |
| 44 | CELH CELSIUS HLDGS INC | Consumer Defensive | 0.8% | $14.4m | 96,215 | – | new |
| 45 | JNJ JOHNSON & JOHNSON | Healthcare | 0.7% | $13.7m | 82,800 | 50% | added |
| 46 | MRVL MARVELL TECHNOLOGY INC | Technology | 0.7% | $13.6m | 226,873 | -22% | reduced |
| 47 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.7% | $12.9m | 454,000 | 0% | held |
| 48 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 0.7% | $12.6m | 2,113,800 | 0% | held |
| 49 | UNP UNION PAC CORP | Industrials | 0.7% | $12.5m | 61,152 | -75% | reduced |
| 50 | REATA PHARMACEUTICALS INC | 0.6% | $11.1m | 108,832 | 621% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.